---
title: Future Disease Areas
description: >-
  Longitudinal evidence infrastructure and adaptive study design for rare and
  complex disease areas — regulatory-grade and built for harder-to-answer
  questions.
category: Page
canonical_url: https://www.pedestalhealth.com/disease-areas/future/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: disease-areas/future
id: 1zCh1fl2gf6PXrV5dWjHgg
contentType: page
---

# Deliberately designed. Built to keep answering.

**Other Disease Areas**

Pedestal Health is actively expanding into additional therapeutic areas where a longitudinal cohort and prospective consent through an embedded site infrastructure would strengthen how evidence is generated. If your program needs a cohort you can draw on continuously to strengthen the decisions ahead, we are here to help.

## Evidence that stands up when it's challenged

Our evidence reflects real patients, real care and real trade-offs. Generated continuously rather than in isolated bursts.



- Less rework, reinterpretation and late-stage risk
- Less skepticism, challenge and re-explanation
- More credibility and acceptance when it counts

![Urban Runners in Motion on City Street](https://images.ctfassets.net/h4s3ip99qawo/75KnthMtJ6ARHgt6OUpIV7/c9b7557fbef492500809cd625d0451e6/iStock-1511827094.jpg)

## Deep clinical and scientific expertise

This only works if you understand both the science and the care setting.



- Study and protocol design grounded in real clinical practice
- Data interpretation informed by how care is actually delivered
- Alignment across clinicians, health systems and life sciences teams

![Pink Liquid Serum with Oil Bubbles Macro Close-Up](https://images.ctfassets.net/h4s3ip99qawo/2yruz7RUj0I5sDaR1k78t1/81fce096f274149a0f9db1b334def938/pexels-luu-thanh-truc-335871-9085814.jpg)


- [Talk to our team](#form) 

## Outcomes

### Move forward without restarting work

### Avoid rework caused by incomplete or disconnected data

### Extend the value of your data across decisions

### Reduce late-stage surprises that slow progress

### Maintain consistency as new questions emerge